Innovative Technology Nalu Medical’s cutting-edge battery-free neurostimulation system, currently FDA-cleared for spinal cord and peripheral nerve stimulation, positions it as a leader in minimally invasive pain management solutions, creating opportunities to expand into new neurological and chronic pain treatment markets.

Market Recognition The company’s consistent recognition, including being named among the top 100 new products worldwide and ranking high in Deloitte’s Technology Fast 500, signals strong differentiation and growth potential that can attract interest from healthcare providers and investors.

Strategic Acquisition Boston Scientific’s planned acquisition for over half a billion dollars highlights Nalu’s valuable position in the neurostimulation space, making it a prime target for partners looking to leverage innovative technologies in large-scale medical device markets.

Product Portfolio Expansion Recent launches of smaller wearable devices and next-gen external therapy discs indicate ongoing product innovation, offering sales opportunities to clinics and hospitals seeking versatile, patient-friendly pain management solutions.

Strong Funding & Growth With recent Series E funding of $20M and revenue estimates between $50M and $100M, Nalu Medical demonstrates solid financial health and growth trajectory, making it an attractive partner for healthcare systems and organizations investing in advanced pain therapies.